Ensysce Biosciences, Inc.

ENSC

Ensysce Biosciences, Inc.

ENSC

Insider Sentiment (TTM):

Last Purchase:2023-03-02Last Sale:2020-06-19Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:470,712Shares Outstanding:6,839,385Institutional Ownership Pct.:6.88%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	1	4	2	2	3	4	4	1	3	1	1
Unbilled Receivables Current	0	-	0	0	1	0	0	2	0	0	0	0
Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	-	1
Prepaid Expense And Other Assets Current	2	1	3	1	2	1	2	3	1	1	1	-
Assets Current	3	2	7	3	5	4	5	9	2	5	2	3
Property Plant And Equipment Net	0	0	0	0	-	-	-	-	-	-	-	-
Other Assets Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Assets	3	2	7	3	6	5	6	9	3	5	3	3
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	2	3	0	1	1	1	2	0	1	2	1
Other Accrued Liabilities Current	2	1	1	1	1	1	1	0	0	0	1	1
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	-	0
Notes Payable Current	0	0	0	0	0	0	0	0	0	0	1	0
Liabilities Current	4	3	5	2	3	2	2	3	1	2	3	2
Liabilities	4	3	5	2	3	2	2	3	1	2	3	2
Stockholders Equity
Liabilities Noncurrent
Other Liabilities Noncurrent	-	-	-	0	0	0	0	-	-	-	0	-
Liabilities Noncurrent	-	-	-	0	0	0	0	0	0	0	0	0
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	145	143	143	138	137	135	133	133	128	128	121	120
Retained Earnings Accumulated Deficit	-146	-143	-140	-137	-133	-131	-130	-126	-127	-125	-122	-118
Stockholders Equity	-1	-0	3	1	3	3	4	7	1	3	-1	1
Minority Interest	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Liabilities And Stockholders Equity	3	2	7	3	6	5	6	9	3	5	3	3
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	2	2	2	2	2	2	2	2	2	2	2	2
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Liquidation Preference Value	1	2	4	-	-	-	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	16	9	5	3	2	2	1	1	1	0	0	0
Shares Outstanding	16	9	5	3	2	2	1	1	1	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-9.29%	1.43%	-8.21%	-	-	-	-	-	-	-	-	-
2025	14.98%	11.59%	-0.97%	-0.70%	18.14%	1.40%	-20.39%	-54.37%	-64.76%	-19.46%	-37.94%	-47.28%
2024	-6.67%	-21.37%	-22.74%	-4.10%	-42.56%	66.67%	-19.11%	-9.63%	-32.13%	-52.59%	-46.79%	-54.04%
2023	-	-	-	-	-	-	7.18%	24.71%	84.71%	1.39%	-29.35%	-27.58%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.70	0.71	1.59	1.27	2.10	2.50	2.42	3.24	1.88	2.87	0.69	1.36
Quick Ratio	0.27	0.26	1.04	0.73	1.36	1.75	1.64	2.12	0.97	2.14	0.37	0.78
Working Capital	-1.22M	-828.28K	2.67M	623.56K	2.77M	2.64M	3.14M	6.29M	1.15M	3.06M	-1.04M	727.27K
Leverage & Debt
Debt to Equity	-5.20	-8.34	1.58	2.63	0.82	0.70	0.66	0.43	0.89	0.48	-5.16	1.39
Interest Coverage TTM	-791.64	-628.42	-545.69	-457.19	-304.59	-148.26	-5.22	-3.88	-5.93	-6.22	-29.76	-204.93
Debt Ratio	1.38	1.31	0.61	0.72	0.45	0.41	0.40	0.30	0.47	0.33	1.24	0.64
Efficiency & Turnover
Asset Turnover TTM	1.06	1.39	0.78	0.71	1.77	1.29	1.25	0.70	0.31	0.39	0.52	0.55
Per Share Metrics
Diluted EPS TTM	-0.97	-1.72	-3.98	-3.80	-2.99	-4.86	-11.45	-12.02	-19.18	-30.42	-70.40	-61.81
Free Cash Flow Per Share TTM	-0.55	-1.42	-3.10	-1.89	-2.04	-4.14	-10.75	-12.95	-16.64	-27.87	-71.42	-59.63
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-281.32%	-251.40%	-202.12%	-245.89%	-89.70%	-110.13%	-129.18%	-142.70%	-671.90%	-572.53%	-480.52%	-437.08%
Net Profit Margin TTM	-280.48%	-250.36%	-200.84%	-244.49%	-88.78%	-109.51%	-153.30%	-179.21%	-784.12%	-661.09%	-476.40%	-404.04%
Growth Metrics
Net Revenue Growth (1Y)	-39.29%	-24.36%	-2.75%	1.51%	415.58%	256.35%	133.58%	40.41%	-51.96%	-35.55%	-11.61%	15.55%
Net Income Growth (1Y)	91.81%	72.92%	27.40%	38.47%	-41.63%	-40.97%	-24.84%	-37.72%	-43.43%	-54.92%	-57.64%	-57.05%
EPS Growth (1Y)	-67.60%	-64.57%	-65.24%	-68.36%	-84.42%	-84.01%	-83.74%	-80.56%	-85.40%	-91.65%	-96.63%	-97.76%
Valuation Metrics
P/E TTM	-0.30	-0.31	-0.23	-0.62	-0.75	-0.53	-0.71	-0.30	-0.40	-0.39	-0.23	-0.33
P/B TTM	-4.84	-10.84	0.82	7.82	1.60	1.32	1.68	0.36	3.02	1.32	-3.68	2.87
P/S TTM	0.84	0.78	0.46	1.52	0.66	0.58	1.09	0.54	3.10	2.58	1.08	1.35
Market Cap	3.78M	3.69M	2.35M	6.84M	4.91M	3.59M	5.68M	2.37M	4.46M	4.50M	2.40M	4.26M
Enterprise Value	3.30M	3.19M	-1.65M	5.55M	3.12M	791.82K	2.48M	-1.39M	3.87M	1.34M	2.13M	3.15M
Calculated Values
Free Cash Flow TTM	-7.19M	-9.72M	-7.93M	-5.46M	-4.49M	-5.80M	-7.50M	-8.54M	-9.78M	-10.58M	-10.78M	-12.27M
Net Debt	-479.86K	-499.63K	-4.00M	-1.29M	-1.79M	-2.80M	-3.20M	-3.77M	-588.77K	-3.16M	-268.91K	-1.11M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-03-02Purchase

Owner: Gower, Bob G

Title: -

Shares: 90,287

Price/Share: $0.49

Value: $44,240.63

Shares Owned: 1,222,682

Relationship: Director

Ownership: Direct

2023-03-01Purchase

Owner: Gower, Bob G

Title: -

Shares: 270,000

Price/Share: $0.48

Value: $129,600.00

Shares Owned: 1,132,395

Relationship: Director

Ownership: Direct

2022-12-09Purchase

Owner: Gower, Bob G

Title: -

Shares: 357,143

Price/Share: $1.40

Value: $500,000.20

Shares Owned: 753,095

Relationship: Director

Ownership: Direct

2022-05-26Purchase

Owner: Kirkpatrick, Lynn

Title: Chief Executive Officer

Shares: 27,000

Price/Share: $0.53

Value: $14,310.00

Shares Owned: 381,851

Relationship: Director,Officer

Ownership: Direct

2020-06-19Sale

Owner: Morgan, Stanley

Title: -

Shares: 776,290

Price/Share: -

Value: -

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-03-02	Gower, Bob G	Director	-	Direct	Purchase	90,287	0.49	$44,240.63	1,222,682	4
2023-03-01	Gower, Bob G	Director	-	Direct	Purchase	270,000	0.48	$129,600.00	1,132,395	4
2022-12-09	Gower, Bob G	Director	-	Direct	Purchase	357,143	1.40	$500,000.20	753,095	4
2022-05-26	Kirkpatrick, Lynn	Director,Officer	Chief Executive Officer	Direct	Purchase	27,000	0.53	$14,310.00	381,851	4
2020-06-19	Morgan, Stanley	TenPercentOwner	-	Indirect	Sale	776,290	-	-	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.88%

Inst. Shares: 470,712

Shares Outstanding: 6,839,385

2025-12-31

18.58%

Inst. Shares: 475,155

Shares Outstanding: 2,557,377

2025-09-30

11.59%

Inst. Shares: 334,491

Shares Outstanding: 2,886,059

2025-06-30

8.00%

Inst. Shares: 176,156

Shares Outstanding: 2,202,299

2025-03-31

24.99%

Inst. Shares: 350,156

Shares Outstanding: 1,401,144

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	470,712	6,839,385	6.88%
2025-12-31	475,155	2,557,377	18.58%
2025-09-30	334,491	2,886,059	11.59%
2025-06-30	176,156	2,202,299	8.00%
2025-03-31	350,156	1,401,144	24.99%
2024-12-31	137,826	697,686	19.75%
2024-09-30	2,397,989	659,361	-
2024-06-30	487,880	587,822	83.00%
2024-03-31	289,203	379,634	76.18%
2023-12-31	41,776	150,937	27.68%
2023-09-30	167,691	205,828	81.47%
2023-06-30	378,893	151,683	249.79%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Ensysce Biosciences, Inc. (ENSC) — SEC Financial Statements & Analysis

Ensysce Biosciences, Inc. (ENSC) is a pharmaceutical preparations company, incorporated in DE. Ensysce Biosciences, Inc. trades on Nasdaq as: ENSC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Ensysce Biosciences, Inc. reported a -39.29% year-over-year revenue growth, a Debt-to-Equity ratio of -5.20x, a Price-to-Sales (P/S) ratio of 0.84x (TTM), a Price-to-Book (P/B) ratio of -4.84x (TTM), at a market cap of $3.78M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -39.29%
Debt To Equity: -5.20x
P/S TTM: 0.84x
P/B TTM: -4.84x
Market Cap: $3.78M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Ensysce Biosciences, Inc. in?

Ensysce Biosciences, Inc. (ENSC) operates in the Pharmaceutical Preparations industry.

What is ENSC's market cap?

Ensysce Biosciences, Inc. (ENSC) has a market capitalization of $3.78M as of 2026-06-30.

What exchange does ENSC trade on?

Ensysce Biosciences, Inc. (ENSC) trades on the Nasdaq.

Where is Ensysce Biosciences, Inc. incorporated?

Ensysce Biosciences, Inc. is incorporated in DE.